Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medco creates chief pharmacist role

Executive Summary

Medco names former M.D. Anderson Cancer Center VP-Pharmacy Roger Anderson as its chief pharmacist, effective July 1. In the newly created position, Anderson will oversee the directors of each of the pharmacy benefit manager's distribution centers and report to Chief Operating Officer Kenneth Klepper. Medco announced the new position one week after it announced a settlement with 20 state attorneys general and agreed to an injunction that settles a portion of the Philadelphia U.S. Attorney's suit against the company (1"The Pink Sheet" May 3, 2004, p. 24)...

You may also be interested in...



Medco Injunction Changes Equation For Switches: PBM Must Cover All Costs

Medco will pay all "drug interchange-related health care costs" incurred by consumers under a consent order entered April 26

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.

Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds

New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043934

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel